论文部分内容阅读
目的分析和研究阿托伐他汀对急性脑梗死患者血清内脂素的水平值影响。方法选取我院2009年11月至2011年11月急性脑梗死患者102例,随机分为两组,即观察组51例与对照组51例。对照组患者临床治疗时采用常规的治疗方法,观察组患者临床治疗时在常规的基础上加用药物阿托伐他汀,两组患者治疗结束后,将其血清内脂素水平进行对比。结果两组患者治疗前血清内脂素的水平值进行对比,两组差异无统计学意义(P>0.05)。两组患者治疗后血清内脂素的水平值与治疗前相比,差异具有统计学意义(P<0.05)。且观察组患者治疗后血清内脂素的水平值显著优于对照组,差异具有统计学意义(P<0.05)。结论药物阿托伐他汀应用于急性脑梗死患者的治疗中,能够有效地降低其血清内脂素的水平值,避免动脉粥样硬化的形成,控制急性脑梗死病发率,值得在临床应用与推广。
Objective To analyze and study the effect of atorvastatin on serum visfatin levels in patients with acute cerebral infarction. Methods A total of 102 patients with acute cerebral infarction from November 2009 to November 2011 in our hospital were randomly divided into two groups (51 in the observation group and 51 in the control group). The patients in the control group were treated with routine therapy. The patients in the observation group were treated with atorvastatin on a routine basis. The levels of serum visfatin in the two groups were compared after treatment. Results The levels of serum visfatin in two groups were compared before and after treatment. There was no significant difference between the two groups (P> 0.05). The levels of serum visfatin after treatment in both groups were significantly different from those before treatment (P <0.05). The level of serum visfatin in the observation group was significantly better than that in the control group, the difference was statistically significant (P <0.05). Conclusion Atorvastatin, used in the treatment of patients with acute cerebral infarction, can effectively reduce the level of serum visfatin, avoid the formation of atherosclerosis and control the incidence of acute cerebral infarction, which is worthy of clinical application. Promotion.